Letroz 2.5 mg Tablets

Letroz is a fertility treatment and hormone-related ailment which consists of Letroz, an aromatase inhibitor. It aids in stimulating ovulation in those women that do not conceive well. Letroz is also applicable in management of hormone-sensitive breast cancer in the postmenopausal women. The administration of this prescription drug is recommended when a gynecologist or an oncologist is present.

Category: Fertility / Ovulation

    Hormone Therapy

   Oncology (Breast Cancer)

Composition:

• Letrozole IP – 2.5 mg
• Marketer: Sun Pharmaceutical Industries Ltd
• Excipients: Lactose monohydrate, Microcrystalline cellulose, Sodium starch glycolate, Maize starch, Colloidal silicon dioxide, Magnesium stearate, Hypromellose, PEG, Titanium dioxide, Iron oxide colorants

• Brand name: Letroz Tablets IP
• Strength and pack: 2.5 mg tablets; carton with 5 × 5 tablets (25 tablets)
• Storage: Store below 25–30°C, protect from moisture and light, keep out of reach of children

Dosage:

• As prescribed by physician